Skip to content

GeneLit

Taming the Medical Literature ~ For Genetic Conditions ~ Hand-Curated • Direct to You

  • Home
  • Subscribe to GeneLit
  • Conditions & Syndromes
    • Genetics of Breast & Ovarian Cancer
  • Topics
  • Contact GeneLit
  • Get LitAlerts
  • Terms and Conditions

Home

    • Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells.
    • Burgess BT, Anderson AM, McCorkle JR, Wu J, Ueland FR, Kolesar JM.
    • Diagnostics (Basel). 2020 Feb 22;10(2). pii: E121. doi: 10.3390/diagnostics10020121.
    • PMID: 32098452
    • PubMed abstract
    • Source abstract
    • Free Full Text
  • Posted on February 29, 2020February 29, 2020Author Steve KopczakCategories Misc

    Post navigation

    Previous Previous post: Previous Post
    Next Next post: Next Post
    Proudly powered by WordPress